Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.

The growing burden of cancer cases globally—primarily driven by increased awareness about the condition and the availability of solutions enabling early diagnosis—is accelerating large-scale adoption of these technologies.

Healthcare providers are opting for these therapies because they facilitate effective tumor removal while sparing healthy tissues, thereby improving patient outcomes.

• Which growth avenues exist for different cancer treatment technology segments like radiation therapies, which work by delivering ionizing energy to damage the DNA of cancer cells, and non-radiation therapies, which kill cancer cells without ionizing radiation?
• How are radiation therapy sectors like biology-guided radiotherapy, brachytherapy, adaptive radiation therapy, electronic brachytherapy, and superficial radiation therapy poised for growth?
• What are the potential growth opportunities for non-radiation therapy segments like histotripsy (focused ultrasound), microwave ablation, aquablation, thermal water vapor therapy, and tumor treating fields?